Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2) Peptide
AGR2
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all AGR2 products
- AGR2 (Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AGR2 antibody (Catalog #: ARP42290_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2) peptide
AGR2 Reactivity: Human, Dog, Mouse Host: Synthetic BP, Imm
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AGR2 (Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2))
- Background
-
AGR2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Increased AGR2 expression is a valuable prognostic factor to predict the clinical outcome of the prostate cancer patients.
Alias Symbols: AG2, GOB-4, HAG-2, XAG-2, PDIA17
Protein Interaction Partner: BRD7,CCDC90B,CRMP1,MED31,POM121,UBQLN4,BRD7,CCDC90B,CRMP1,MED31,POM121
Protein Size: 175 - Molecular Weight
- 20 kDa
- Gene ID
- 10551
- NCBI Accession
- NM_006408, NP_006399
- UniProt
- O95994
-
You are here:
